Misplaced Pages

Clofibride: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editContent deleted Content addedVisualWikitext
Revision as of 14:11, 12 August 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_P← Previous edit Latest revision as of 11:21, 23 January 2023 edit undoEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers173,284 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper 
(21 intermediate revisions by 16 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{drugbox
{{Missing information|everything|date=January 2017}}
| UNII_Ref = {{fdacite|correct|FDA}}
{{Drugbox
| UNII = 0S9SLS3L93
| verifiedrevid = 437132997 | verifiedrevid = 447821444
| IUPAC_name = 3-(dimethylcarbamoyl)propyl 2-(4-chlorophenoxy)-2-methylpropanoate | IUPAC_name = 3-(dimethylcarbamoyl)propyl 2-(4-chlorophenoxy)-2-methylpropanoate
| image = Clofibride.svg | image = Clofibride.svg

<!--Clinical data-->
| tradename =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism = ] to ]; ] ]
| elimination_half-life = 12 hours (clofibric acid)
| excretion = ] (mostly) and fecal

<!--Identifiers-->
| CAS_number = 26717-47-5
| ATC_prefix = C10
| ATC_suffix = AB10
| PubChem = 160134
| ChEMBL = 1697831
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 140758 | ChemSpiderID = 140758
| UNII_Ref = {{fdacite|correct|FDA}}
| InChI = 1/C16H22ClNO4/c1-16(2,22-13-9-7-12(17)8-10-13)15(20)21-11-5-6-14(19)18(3)4/h7-10H,5-6,11H2,1-4H3
| UNII = 0S9SLS3L93
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07188

<!--Chemical data-->
| C=16 | H=22 | Cl=1 | N=1 | O=4
| smiles = Clc1ccc(OC(C(=O)OCCCC(=O)N(C)C)(C)C)cc1 | smiles = Clc1ccc(OC(C(=O)OCCCC(=O)N(C)C)(C)C)cc1
| InChIKey = CXQGFLBVUNUQIA-UHFFFAOYAF
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H22ClNO4/c1-16(2,22-13-9-7-12(17)8-10-13)15(20)21-11-5-6-14(19)18(3)4/h7-10H,5-6,11H2,1-4H3 | StdInChI = 1S/C16H22ClNO4/c1-16(2,22-13-9-7-12(17)8-10-13)15(20)21-11-5-6-14(19)18(3)4/h7-10H,5-6,11H2,1-4H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = CXQGFLBVUNUQIA-UHFFFAOYSA-N | StdInChIKey = CXQGFLBVUNUQIA-UHFFFAOYSA-N
| CAS_number = 26717-47-5
| ATC_prefix = C10
| ATC_suffix = AB10
| PubChem = 160134
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07188
| C=16|H=22|Cl=1|N=1|O=4
| molecular_weight = 327.803 g/mol
| bioavailability =
| protein_bound =
| metabolism = ] to clofibric acid; ] ]
| elimination_half-life = 12 hours (clofibric acid)
| excretion = ] (mostly) and fecal
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category=
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =
}} }}

'''Clofibride''' is a ].
'''Clofibride''' is a ]. Clofibride is a derivative of ]. In the body it is converted into 4-chlorophenoxyisobutyric acid (]),<ref>{{Cite web|url=https://pubchem.ncbi.nlm.nih.gov/compound/160134|title=Clofibride}}</ref> which is the true ].<ref name="römpp">{{RömppOnline|Name=Clofibrat |Datum=06. Mai 2020 |ID=RD-03-02073 }}</ref> So clofibride, just like clofibrate is a ] of clofibric acid.

==References==
{{Reflist|2}}


{{Lipid modifying agents}} {{Lipid modifying agents}}
{{PPAR modulators}}


] ]
] ]
] ]
] ]
]




{{cardiovascular-drug-stub}} {{cardiovascular-drug-stub}}

]

Latest revision as of 11:21, 23 January 2023

Chemical compound
This article is missing information about everything. Please expand the article to include this information. Further details may exist on the talk page. (January 2017)
Pharmaceutical compound
Clofibride
Clinical data
ATC code
Pharmacokinetic data
MetabolismHydrolyzed to clofibric acid; hepatic glucuronidation
Elimination half-life12 hours (clofibric acid)
ExcretionRenal (mostly) and fecal
Identifiers
IUPAC name
  • 3-(dimethylcarbamoyl)propyl 2-(4-chlorophenoxy)-2-methylpropanoate
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.043.542 Edit this at Wikidata
Chemical and physical data
FormulaC16H22ClNO4
Molar mass327.81 g·mol
3D model (JSmol)
SMILES
  • Clc1ccc(OC(C(=O)OCCCC(=O)N(C)C)(C)C)cc1
InChI
  • InChI=1S/C16H22ClNO4/c1-16(2,22-13-9-7-12(17)8-10-13)15(20)21-11-5-6-14(19)18(3)4/h7-10H,5-6,11H2,1-4H3
  • Key:CXQGFLBVUNUQIA-UHFFFAOYSA-N
  (verify)

Clofibride is a fibrate. Clofibride is a derivative of clofibrate. In the body it is converted into 4-chlorophenoxyisobutyric acid (clofibric acid), which is the true hypolipidemic agent. So clofibride, just like clofibrate is a prodrug of clofibric acid.

References

  1. "Clofibride".
  2. Entry on Clofibrat. at: Römpp Online. Georg Thieme Verlag, retrieved 06. Mai 2020.
Lipid-lowering agents (C10)
GI tract
Cholesterol absorption inhibitors, NPC1L1
Bile acid sequestrants/resins (LDL)
Liver
Statins (HMG-CoA reductase, LDL)
Niacin and derivatives (HDL and LDL)
MTTP inhibitors (VLDL)
ATP citrate lyase inhibitors (LDL)
Thyromimetics (VLDL)
Blood vessels
PPAR agonists (LDL)
Fibrates
Others
CETP inhibitors (HDL)
PCSK9 inhibitors (LDL)
ANGPTL3 inhibitors (LDL/HDL)
Combinations
Other
PPARTooltip Peroxisome proliferator-activated receptor modulators
PPARαTooltip Peroxisome proliferator-activated receptor alpha
PPARδTooltip Peroxisome proliferator-activated receptor delta
PPARγTooltip Peroxisome proliferator-activated receptor gamma
Non-selective
See also
Receptor/signaling modulators


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

Categories: